HomeRGRX • OTCMKTS
add
RegeneRx Biopharmaceuticals Inc
Previous close
$0.0014
Year range
$0.0012 - $0.073
Market cap
2.10K USD
Avg Volume
83.00
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2023info | Y/Y change |
|---|---|---|
Revenue | 19.19K | — |
Operating expense | 324.10K | — |
Net income | -385.20K | — |
Net profit margin | -2.01K | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2023info | Y/Y change |
|---|---|---|
Cash and short-term investments | 101.56K | — |
Total assets | 186.81K | — |
Total liabilities | 3.93M | — |
Total equity | -3.74M | — |
Shares outstanding | 1.44M | — |
Price to book | -0.00 | — |
Return on assets | -267.94% | — |
Return on capital | 35.88% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2023info | Y/Y change |
|---|---|---|
Net income | -385.20K | — |
Cash from operations | -189.33K | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -189.33K | — |
Free cash flow | -85.61K | — |
About
Founded
1982
Headquarters
Website
Employees
3
